Technical Analysis for MYL - Mylan Inc.

Grade Last Price % Change Price Change
grade C 21.69 -2.47% -0.55
MYL closed down 2.47 percent on Friday, September 13, 2019, on 72 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical MYL trend table...

Date Alert Name Type % Chg
Upper Bollinger Band Walk Strength 0.00%
Outside Day Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Stochastic Sell Signal Bearish -2.47%
Upper Bollinger Band Walk Strength -2.47%
Overbought Stochastic Strength -2.47%
Upper Bollinger Band Touch Strength -2.47%
Pocket Pivot Bullish Swing Setup -3.73%
Upper Bollinger Band Walk Strength -3.73%

Older signals for MYL ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Mylan Inc. engages in the development, manufacture, marketing, licensing, and distribution of generic and branded generic pharmaceuticals, specialty pharmaceuticals, and active pharmaceutical ingredients (APIs) worldwide. It operates in two segments, Generics and Specialty. The Generics segment primarily develops, manufactures, sells, and distributes generic or branded generic pharmaceutical products in tablet, capsule, and injectable or transdermal patch forms, as well as API. It also focuses on developing APIs with non-infringing processes to partner with manufacturers. This segment serves proprietary and ethical pharmaceutical wholesalers and distributors, group purchasing organizations, drug store chains, independent pharmacies, drug manufacturers, institutions, and public and governmental agencies. The Specialty segment manufactures and sells branded specialty injectable, nebulized, and transdermal products for life-threatening conditions. Its products include EpiPen Auto-Injector to treat severe allergic reactions; and Perforomist Inhalation Solution, a formoterol fumarate inhalation solution for the maintenance treatment of bronchoconstriction in chronic obstructive pulmonary disorder patients. This segment serves pharmaceutical wholesalers and distributors, pharmacies, and healthcare institutions. The company also manufactures and sells injectable products in various therapeutic areas for the hospital setting; supplies APIs for the manufacture of antiretroviral (ARV) drugs to treat HIV/AIDS; offers finished dosage form (FDF) products in the ARV market; and manufactures non-ARV FDF products, as well as focuses on developing, manufacturing, and commercializing dry powder inhaler delivery platform. Mylan Inc. has a strategic collaboration with Pfizer Japan Inc. The company was formerly known as Mylan Laboratories Inc. and changed its name to Mylan Inc. in October 2007. Mylan Inc. was founded in 1961 and is based in Canonsburg, Pennsylvania.
Health Life Sciences Pharmaceutical Industry Pharmaceuticals Pharmaceutical Industry In China Pharmaceuticals Policy Active Pharmaceutical Ingredients HIV/Aids Generic Drug Healthcare Institutions Disorder Generic Pharmaceutical Products Pharmaceutical Wholesalers Drug Manufacturers Injectable Products
Is MYL a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 39.59
52 Week Low 16.63
Average Volume 7,444,291
200-Day Moving Average 24.4521
50-Day Moving Average 19.4038
20-Day Moving Average 19.9295
10-Day Moving Average 20.88
Average True Range 0.9013
ADX 24.35
+DI 35.7344
-DI 11.4172
Chandelier Exit (Long, 3 ATRs ) 20.1961
Chandelier Exit (Short, 3 ATRs ) 20.2839
Upper Bollinger Band 22.4758
Lower Bollinger Band 17.3832
Percent B (%b) 0.85
BandWidth 25.553075
MACD Line 0.7694
MACD Signal Line 0.4696
MACD Histogram 0.2997
Fundamentals Value
Market Cap 11.63 Billion
Num Shares 536 Million
EPS 1.24
Price-to-Earnings (P/E) Ratio 17.49
Price-to-Sales 1.72
Price-to-Book 1.61
PEG Ratio 1.59
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 23.55
Resistance 3 (R3) 23.75 23.32 23.24
Resistance 2 (R2) 23.32 22.85 23.23 23.14
Resistance 1 (R1) 22.51 22.56 22.30 22.31 23.03
Pivot Point 22.08 22.08 21.98 21.99 22.08
Support 1 (S1) 21.27 21.61 21.06 21.07 20.35
Support 2 (S2) 20.84 21.32 20.75 20.24
Support 3 (S3) 20.03 20.84 20.14
Support 4 (S4) 19.83